Virax Biolabs Group Limited (VRAX)
Nasdaq: VRAX · In Vitro & In Vivo Diagnostic Substances · Lanarkshire, GB · filing with the SEC since 2021
Filings
152 filings since 2017 beside 7 insider forms · Non-accelerated filer and emerging growth company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and emerging growth company
20-F
Annual report, foreign filer for the fiscal year ending Mar 31, 2027Foreign filers have four months after the fiscal year ends.
by Jul 29, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files.
Filings a yearinsider forms included
14937211932
2026 counts to Nov 13, 2026.
SEC letters: 3 in the last 36 months, the newest Dec 29, 2025.A late-filing notice, Form NT 20-F, filed Aug 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
40 of 152 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.